Welcome to the Department of Radiation Oncology

Message from James M. Metz, MD — Chairman

Penn Radiation Oncology is dedicated to a three-part mission of excellence in patient care, basic and translational research, and the education of residents and students. We are committed to delivering excellence in every area and as such we steadfastly believe that "Excellence is Standard."

Penn Radiation Oncology is one of the most comprehensive radiation oncology programs in the world. The outstanding faculty and staff, combined with Penn’s extensive collection of advanced technology, gives patients access to nearly every treatment option available for their cancer. The broad range of radiation treatments available include proton therapy, intensity-modulated radiation therapy (IMRT), high-dose rate (HDR) and low-dose rate brachytherapy, partial breast irradiation, stereotactic radiosurgery (SRS), and Gamma Knife radiation. With the Abramson Cancer Center of the University of Pennsylvania, Penn Radiation Oncology provides patient care at the Ruth and Raymond Perelman Center for Advanced Medicine and seven community-based sites.

Read more of the Message from the Chair »

News

  • Dogs Paving Way for Potential New Cancer Treatment for Humans Thursday, December 8, 2022

    A new study led by Keith A. Cengel, MD, PhD, an associate professor of Radiation Oncology, and Brian Flesner, DVM, an associate professor of Clinical Oncology in the School of Veterinary Medicine, is evaluating the safety and efficacy of treating oral cancer in dogs with a palliative radiation in just two clinic visits. If the treatment, known as FLASH radiotherapy, is successful for animals, it's expected to pave the way for clinical trials in human patients. CBS News

  • A FLASH of radiation may lead to new cancer care for people and pets alike Thursday, November 10, 2022

    Palliative radiation therapy for cancer may slow or stop tumor growth and alleviate pain, but in veterinary medicine it is traditionally delivered over the course of several weeks. A new study led by Keith Cengel of the Perelman School of Medicine and Brian Flesner of the School of Veterinary Medicine is evaluating if palliative radiation delivered in just two clinic visits is safe and similar in efficacy to the alternative, treating dogs with oral cancer like Maple, a 13-year-old Labrador retriever owned by Penn Vet alum Meg Ruller.

  • Machine-learning Approach Using Step Counts Predicts Hospitalization During Radiotherapy Friday, October 28, 2022

    An artificial intelligence model appeared to predict the likelihood of unplanned hospitalizations during chemoradiation therapy among a cohort of patients with various cancer types. Ying Xiao, PhD, a professor of Radiation Oncology, commented on the results, which were presented at the American Society for Radiation Oncology annual meeting.

    HemOnc Today

More News

Upcoming Events

    More Events